ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,259Medicare Part D Prescriptions Filled, Including Refills

Rank: 296 out of 2061

$767K Total Retail Price of All Prescriptions

Rank: 269 out of 2061

568 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 568 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 568 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,159 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 486 427 1 3
LISINOPRIL 440 347 2 2
PRAVASTATIN SODIUM 399 328 3 14
ATORVASTATIN CALCIUM 382 329 4 8
SIMVASTATIN 380 327 5 1
OMEPRAZOLE 378 331 6 5
AMLODIPINE BESYLATE 289 242 7 4
METOPROLOL TARTRATE 282 232 8 7
METFORMIN HCL 239 175 9 9
HYDROCODONE-ACETAMINOPHEN 211 146 S3 10 10
FUROSEMIDE 200 166 11 6
CITALOPRAM HBR 198 161 12 20
HYDROCHLOROTHIAZIDE 194 165 13 12
METOPROLOL SUCCINATE 164 161 14 19
AZITHROMYCIN 164 136 14 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 146 134 16 27
TRAMADOL HCL 144 112 17 18
ZOLPIDEM TARTRATE 138 131 18 23
GLIMEPIRIDE 136 96 19 33
ALLOPURINOL 132 120 20 28
GABAPENTIN 129 94 21 15
GLIPIZIDE 119 106 22 55
ADVAIR DISKUS 118 100 23 57
CLOPIDOGREL 114 102 24 29
PREDNISONE 113 82 25 32
LOVASTATIN 105 96 26 35
MELOXICAM 100 80 27 44
WARFARIN SODIUM 99 83 28 11
FLUOXETINE HCL 99 83 28 73
NEXIUM 96 47 30 26
LOSARTAN POTASSIUM 94 85 31 17
ATENOLOL 93 92 32 13
AMILORIDE-HYDROCHLOROTHIAZIDE 92 76 33 317
PLAVIX 90 83 34 49
OXYCODONE-ACETAMINOPHEN 86 64 S2 35 36
ALENDRONATE SODIUM 85 83 36 25
PROAIR HFA 83 48 37 40
POTASSIUM CHLORIDE 81 74 38 16
EVISTA 75 75 39 150
CYMBALTA 72 42 40 59
FLUTICASONE PROPIONATE 72 50 40 43
CRESTOR 71 67 42 31
CELEBREX 70 39 43 91
SERTRALINE HCL 63 42 44 21
PANTOPRAZOLE SODIUM 62 54 45 45
GLYBURIDE-METFORMIN HCL 60 56 R 46 181
ESCITALOPRAM OXALATE 58 52 47 77
LIPITOR 58 42 47 70
OXYBUTYNIN CHLORIDE ER 56 51 49 80
DONEPEZIL HCL 55 55 50 24
TAMSULOSIN HCL 55 50 50 30
LOSARTAN-HYDROCHLOROTHIAZIDE 55 50 50 50
NAMENDA 54 54 53 37
FENOFIBRATE 53 28 54 65
ROPINIROLE HCL 52 43 55 92
LANSOPRAZOLE 52 51 55 139
ZETIA 50 50 57 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.